333. DPH Biologicals’ Alex Cochran on a maturing ag biologics market + the importance of clearly stated ROI for growers

Agbioscience

Content provided by AgriNovus Indiana. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by AgriNovus Indiana or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

5M ago 19:20

MP3•Episode home

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on April 30, 2025 09:33 (3d ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

New data from AgFunder News shows that ag biologics are used by just under half of U.S. farmers. Dr. Alex Cochran, CTO of DPH Biologicals, joins today to share his unique perspective on this growing market.

We discuss:

What are ag biologicals and their role in modern production agriculture.
Biologicals as an important piece for growers as they manage a tough farm economy.
The challenge of change when it comes to farming practices and the criticality of clearly describing ROI for growers.
Movement in the biologicals market from big players like Corteva’s acquisition of Symborg and Stoller.
DPH’s focus on differentiation and value to its growers + a deep dive into the conversations they’re having at the farmgate right now.

The biologicals market has come a long way, but is it still early innings? Alex talks how the technology has evolved what’s on the horizon for DPH Biologicals.

360 episodes